Literature DB >> 26186448

Treatment of recurrent metastatic uterine leiomyosarcoma of the spine: a multimodality approach using resection, radiosurgery, and chemotherapy.

Michael J Strong1,2,3, Trevor Rosenlof1, Siddhartha Padmanabha4, Roy S Weiner1,3,5, Lee Roy Morgan6, Marcus I Ware7.   

Abstract

The authors describe the case of a patient who initially presented with uterine leiomyosarcoma (LMS) that later metastasized to the spine. The patient was treated at another institution for her primary uterine LMS, undergoing resection followed by adjuvant chemotherapy. After several years of disease remission, the patient presented in January 2011 to the authors' institution with recurrent uterine LMS metastatic to the spine, which has been treated with multiple therapeutic modalities in a combination of surgery, radiosurgery, and chemotherapy. As a result of this approach, the patient has been progression free for 35 months since her presentation (April 2011 to March 2014). We herein describe our experience treating this patient with recurrent uterine LMS of the spine and suggest that patients with recurrent uterine LMSs should be considered for treatment using a multimodality approach with emphasis on enrollment into clinical trials.

Entities:  

Keywords:  4-demethyl-4-cholesteryloxycarbonylpenclomedine; DM-CHOC-PEN; DM-CHOC-PEN: 4-demethyl-4-cholesteryloxycarbonylpenclomedine; LMS = leiomyosarcoma; TAHBSO = total abdominal hysterectomy and bilateral salphingo-oophorectomy; TMZ = temozolomide; chemotherapy; multimodality treatment; oncology; radiosurgery; recurrence; spinal metastasis; uterine leiomyosarcoma

Year:  2015        PMID: 26186448      PMCID: PMC4715988          DOI: 10.3171/2015.1.SPINE14640

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  27 in total

1.  Sarcoma of the uterus.

Authors:  E SCHJOTT-RIVERS
Journal:  Acta Obstet Gynecol Scand       Date:  1949       Impact factor: 3.636

2.  Intralesional resection of primary and metastatic sarcoma involving the spine: outcome analysis of 59 patients.

Authors:  M H Bilsky; P J Boland; K S Panageas; J M Woodruff; M F Brennan; J H Healey
Journal:  Neurosurgery       Date:  2001-12       Impact factor: 4.654

3.  Thoracic vertebral bone metastasis from uterine leiomyosarcoma.

Authors:  M Takemori; R Nishimura; K Sugimura; M Mitta
Journal:  Gynecol Oncol       Date:  1993-11       Impact factor: 5.482

Review 4.  Leiomyosarcoma metastases to the spine. Case series and review of the literature.

Authors:  Mohamed Samy A Elhammady; Glen R Manzano; Nathan Lebwohl; Allan D Levi
Journal:  J Neurosurg Spine       Date:  2007-02

5.  Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy.

Authors:  Robert L Giuntoli; Daniel S Metzinger; Connie S DiMarco; Stephen S Cha; Jeff A Sloan; Gary L Keeney; Bobbie S Gostout
Journal:  Gynecol Oncol       Date:  2003-06       Impact factor: 5.482

6.  Leiomyosarcoma of the uterus.

Authors:  T Van Dinh; J D Woodruff
Journal:  Am J Obstet Gynecol       Date:  1982-12-01       Impact factor: 8.661

7.  The treatment of uterine sarcomas.

Authors:  P Reichardt
Journal:  Ann Oncol       Date:  2012-09       Impact factor: 32.976

8.  Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study.

Authors:  F J Major; J A Blessing; S G Silverberg; C P Morrow; W T Creasman; J L Currie; E Yordan; M F Brady
Journal:  Cancer       Date:  1993-02-15       Impact factor: 6.860

9.  Pelvic radiation improves local control after hysterectomy for uterine leiomyosarcoma: a 20-year experience.

Authors:  Ali Mahdavi; Bradley J Monk; Jennifer Ragazzo; Mark I Hunter; Scot E Lentz; Steven A Vasilev; Krishnansu S Tewari
Journal:  Int J Gynecol Cancer       Date:  2009-08       Impact factor: 3.437

10.  Carbonate and carbamate derivatives of 4-demethylpenclomedine as novel anticancer agents.

Authors:  Lee Roy Morgan; Robert F Struck; William R Waud; Blaise LeBlanc; Andrew H Rodgers; Branko S Jursic
Journal:  Cancer Chemother Pharmacol       Date:  2009-03-03       Impact factor: 3.333

View more
  1 in total

1.  Integrated approach to pain management for a patient with multiple bone metastases of uterine cervical cancer.

Authors:  De-An Qin; Jie-Fu Song; Li-Ping Song; Gui-Sheng Feng
Journal:  J Int Med Res       Date:  2018-03-20       Impact factor: 1.671

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.